- Home
- Meeting Calendar
- Event Details
TAC Meeting |
|
March 21, 2023
09:30 AM |
|
ERCOT Austin
8000 Metropolis (Building E), Suite 100
Austin, TX 78744 Rooms A, B, and C
|
Teleconference: 877-668-4493
Meeting number: 2557 099 0806
Meeting password: P4#9wX
|
Comments
Agenda
1. |
Antitrust Admonition |
Clif Lange |
9:30 a.m. |
2. |
Approval of TAC Meeting Minutes (Possible Vote) |
Clif Lange |
9:35 a.m. |
|
|
|
|
3. |
Meeting Updates |
Clif Lange |
9:40 a.m. |
|
|
|
|
4. |
Review of ERCOT Market Impact Statements/Opinions and IMM Opinions |
Ann Boren/ Carrie Bivens |
9:50 a.m. |
5. |
PRS Report (Vote) |
Martha Henson |
9:55 a.m. |
|
|
|
|
|
|
|
|
|
|
|
|
6. |
Other Binding Documents |
|
10:15 a.m. |
|
|
David Maggio |
|
7. |
Revision Requests Tabled at TAC (Vote) |
Clif Lange |
10:25 a.m. |
|
|
|
|
8. |
RMS Report (Vote) |
Debbie McKeever |
10:35 a.m. |
|
|
|
|
|
|
|
|
|
|
|
|
9. |
ROS Report (Vote) |
Chase Smith |
10:55 a.m. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10. |
WMS Report (Vote) |
Eric Blakey |
11:15 a.m. |
|
|
|
|
|
|
|
|
|
|
|
|
11. |
Market Credit Working Group (MCWG) Report (Vote) |
Brenden Sager |
11:25 a.m. |
|
|
|
|
12. |
TAC Procedures (Vote) |
Clif Lange |
11:45 a.m. |
13. |
Phase 2 Bridging Options (Possible Vote) |
Kenan Ogelman |
11:55 a.m. |
14. |
ERCOT Reports |
|
12:30 p.m. |
|
|
David Maggio |
|
|
|
David Kezell/Jeff Billo |
|
|
|
Matt Mereness |
|
|
|
|
|
15. |
Other Business |
|
1:15 p.m. |
16. |
Combo Ballot (Vote) |
Clif Lange |
1:20 p.m. |
|
Adjourn |
|
1:25 p.m. |
Scheduled TAC Meetings
- Jan 24, 2023 - TAC Meeting
- Feb 20, 2023 - TAC Meeting
- Mar 21, 2023 - TAC Meeting
- Mar 29, 2023 - Special TAC Meeting (CANCELLED)
- Mar 31, 2023 - Special TAC Meeting
- Apr 10, 2023 - Special TAC Meeting - Webex Only
- Apr 25, 2023 - TAC Meeting (CANCELLED)
All information is posted as Public in accordance with the ERCOT Websites Content Management Corporate Standard.
TAC Standing Representatives are asked to do the following:
An email with a unique validation code will be sent to all TAC Standing Representatives and their designated Alternative Representatives